ArticleViruses2021

Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H.

Ahmet Hazini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.